ATE323693T1 - Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen - Google Patents

Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Info

Publication number
ATE323693T1
ATE323693T1 AT01981239T AT01981239T ATE323693T1 AT E323693 T1 ATE323693 T1 AT E323693T1 AT 01981239 T AT01981239 T AT 01981239T AT 01981239 T AT01981239 T AT 01981239T AT E323693 T1 ATE323693 T1 AT E323693T1
Authority
AT
Austria
Prior art keywords
treatment
pain
calcium channel
type calcium
channel antagonists
Prior art date
Application number
AT01981239T
Other languages
English (en)
Inventor
Bipinchandra Chaudhari
Marc Chapdelaine
Greg Hostetler
Lucius Kemp
John Mccauley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Application granted granted Critical
Publication of ATE323693T1 publication Critical patent/ATE323693T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01981239T 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen ATE323693T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0004053A SE0004053D0 (sv) 2000-11-06 2000-11-06 N-type calcium channel antagonists for the treatment of pain

Publications (1)

Publication Number Publication Date
ATE323693T1 true ATE323693T1 (de) 2006-05-15

Family

ID=20281713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01981239T ATE323693T1 (de) 2000-11-06 2001-10-31 Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen

Country Status (9)

Country Link
US (1) US6815447B2 (de)
EP (1) EP1339706B1 (de)
JP (1) JP2004513125A (de)
AT (1) ATE323693T1 (de)
AU (1) AU2002212894A1 (de)
DE (1) DE60118956T2 (de)
ES (1) ES2261496T3 (de)
SE (1) SE0004053D0 (de)
WO (1) WO2002036586A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040259866A1 (en) * 1998-06-30 2004-12-23 Snutch Terrance P. Calcium channel blockers comprising two benzhydril moieties
PL375552A1 (en) * 2002-05-22 2005-11-28 Amgen Inc. Vanilloid receptor ligands and their medical applications
EP2270006A1 (de) 2002-08-08 2011-01-05 Amgen, Inc Pyridazin-Derivate zur Verwendung als Vanilloidrezeptorliganden
US7419984B2 (en) * 2002-10-17 2008-09-02 Cell Therapeutics, Inc. Pyrimidines and uses thereof
ATE527250T1 (de) 2002-11-21 2011-10-15 Novartis Ag 2,4,6-trisubstituierten pyrimidinen als phosphotidylinositol (pi) 3-kinase inhibitoren und deren verwendung zur behandlung von krebs
JP4691041B2 (ja) * 2003-11-20 2011-06-01 チルドレンズ ホスピタル メディカル センター Ｇｔｐアーゼ阻害剤および使用方法
WO2006089311A1 (en) 2005-02-15 2006-08-24 Amgen Inc. Vanilloid receptor ligands and their use in treatments
EP1871372A4 (de) * 2005-04-08 2010-06-02 Neuromed Pharmaceuticals Ltd Kombinationstherapie mit einem calciumkanalblocker vom n-typ zur schmerzminderung
JO2660B1 (en) 2006-01-20 2012-06-17 نوفارتيس ايه جي Pi-3 inhibitors and methods of use
US8362021B2 (en) * 2006-05-11 2013-01-29 Zalicus Pharmaceuticals Ltd. Method for increasing the bioavailability of benzhydryl piperazine containing compounds
AU2008213808B2 (en) 2007-02-06 2011-11-10 Novartis Ag PI 3-kinase inhibitors and methods of their use
JP5860417B2 (ja) * 2010-03-04 2016-02-16 メルク・シャープ・エンド・ドーム・コーポレイション カテコールｏ−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用
MX336711B (es) 2010-03-04 2016-01-28 Merck Sharp & Dohme Inhibidores de catecol o-metil transferasa y su uso en el tratamiento de transtornos psicoticos.
CA2789471C (en) * 2010-03-04 2018-01-02 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
EP2654726A1 (de) 2011-03-08 2013-10-30 Zalicus Pharmaceuticals Ltd. Festdispersionsformulierungen und verwendungsverfahren dafür
US8409560B2 (en) 2011-03-08 2013-04-02 Zalicus Pharmaceuticals Ltd. Solid dispersion formulations and methods of use thereof
AU2012313888B2 (en) 2011-09-27 2016-03-31 Novartis Ag 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
UY34632A (es) 2012-02-24 2013-05-31 Novartis Ag Compuestos de oxazolidin- 2- ona y usos de los mismos
US9296733B2 (en) 2012-11-12 2016-03-29 Novartis Ag Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases
KR20150131224A (ko) 2013-03-14 2015-11-24 노파르티스 아게 돌연변이 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB794043A (en) * 1955-06-03 1958-04-30 Ici Ltd New quinoline derivatives
HUP0101275A3 (en) * 1998-03-26 2002-12-28 Japan Tobacco Inc Amide derivatives and pharmaceutical compositions containing them as nociceptin antagonists

Also Published As

Publication number Publication date
US6815447B2 (en) 2004-11-09
JP2004513125A (ja) 2004-04-30
AU2002212894A1 (en) 2002-05-15
SE0004053D0 (sv) 2000-11-06
WO2002036586A1 (en) 2002-05-10
ES2261496T3 (es) 2006-11-16
DE60118956D1 (de) 2006-05-24
US20040058945A1 (en) 2004-03-25
DE60118956T2 (de) 2007-03-15
EP1339706A1 (de) 2003-09-03
EP1339706B1 (de) 2006-04-19

Similar Documents

Publication Publication Date Title
DE60118956D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
ATE296094T1 (de) Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen
ATE455092T1 (de) Substituierte tetracyclin-verbindungen zur behandlung von malaria
DE60204232D1 (de) Antagonisten für calciumkanäle vom n-typ zur behandlung von schmerzen
CA2366932A1 (en) Cyclic protein tyrosine kinase inhibitors
DE60135732D1 (de) Topoisomerasehemmern zur behandlung von chirurgischen verklebungen
IS6658A (is) Ný efnasambönd
ATE284690T1 (de) Antithrombotische diamine
DE60035057D1 (de) CD40 Antagonist zur Behandlung von Psoriasis
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
CY1109361T1 (el) Υποκατεστημενες 4-αμινοκυκλοεξανολες
SE0004054D0 (sv) N-type calcium channel antagonists for the treatment of pain
SE9802208D0 (sv) Novel compounds
DE502005008058D1 (de) Gesättigte und ungesättigte 3-pyridyl-benzocycloalkylmethyl-amine zur behandlung von schmerzen, depressionen und angstzuständen
SE0003476D0 (sv) Compounds
TR199700834T1 (xx) 1-Aril-2-Akilamino ethan bile�ikleri ve bunlar�n n�rokinin olarak �zellikle n�rokinin 1 has�mlar� olarak kullan�mlar�.
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
SE0303280D0 (sv) Novel compounds
ATE321045T1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
DE60137534D1 (de) Calciumkanalantagonisten vom n-typ zur behandlung von schmerzen
SE9802209D0 (sv) Novel compounds
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
EA200300556A1 (ru) Композиция n-(метилэтиламинокарбонил)-4-(3-метилфениламино)-3-пиридилсульфонамида и циклических олигосахаридов
SE0004055D0 (sv) N-type calcium channel antagonists for the treatment of pain

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties